​

Ocugen (OCGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OCGN Stock Forecast

Ocugen (OCGN) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $6.00 and a low of $3.50. This represents a 101.61% increase from the last price of $2.48.

- $1 $2 $3 $4 $5 $6 High: $6 Avg: $5 Low: $3.5 Last Closed Price: $2.48

OCGN Stock Rating

Ocugen stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

OCGN Price Target Upside V Benchmarks

TypeNameUpside
StockOcugen101.61%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.48$2.48$2.48
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2614---5
Feb, 2614---5
Jan, 2614---5
Dec, 2514---5
Nov, 2523---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 23, 2022Uy EarMizuho Securities$5.00$2.34113.68%101.61%
Aug 15, 2022H.C. Wainwright$6.00$2.88108.33%141.94%
Jun 18, 2022Jennifer KimCantor Fitzgerald$4.50$2.16108.33%81.45%
May 08, 2022Daniil GataulinChardan Capital$3.50$2.1662.04%41.13%
Apr 25, 2022Zegbeh JallahRoth Capital$6.00$2.40150.00%141.94%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 11, 2026OppenheimerOutperforminitialise
Oct 15, 2024Maxim GroupBuyinitialise
May 15, 2024H.C. WainwrightBuyBuyhold
Mar 01, 2023Cowen & Co.Outperforminitialise
Jun 18, 2022Cantor FitzgeraldOverweightOverweightinitialise
Apr 25, 2022Roth CapitalBuyBuyhold
Jun 07, 2021Roth CapitalBuyBuyhold
Feb 27, 2021H.C. WainwrightBuyBuyupgrade
Feb 09, 2021Chardan CapitalBuydowngrade
Feb 08, 2021Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.30$-0.40$-0.26$-0.20$-0.23---
Avg Forecast$-0.30$-0.38$-0.29$-0.20$-0.26$-0.22$0.39$0.20
High Forecast$-0.19$-0.34$-0.28$-0.18$-0.19$-0.20$1.23$0.20
Low Forecast$-0.53$-0.51$-0.29$-0.22$-0.30$-0.23$-0.09$0.20
Surprise %-5.26%-10.34%--11.54%---

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$2.49M$6.04M$4.05M$4.41M---
Avg Forecast$91.97M$2.17M$6.04M$3.62M$40.32M$20.57M$99.54M$219.66M
High Forecast$110.36M$2.75M$6.04M$4.47M$40.32M$20.57M$99.54M$219.66M
Low Forecast$73.58M$1.97M$6.04M$3.20M$40.32M$20.57M$99.54M$219.66M
Surprise %-14.83%-11.93%-89.05%---

Net Income Forecast

$-150M $-50M $50M $150M $250M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-58.37M$-86.80M$-63.08M$-54.05M$-67.85M---
Avg Forecast$-87.96M$-92.84M$-69.63M$-51.14M$-59.53M$-52.53M$-8.34M$47.64M
High Forecast$-70.37M$-81.86M$-67.23M$-44.53M$-46.15M$-48.87M$300.52M$47.64M
Low Forecast$-105.56M$-125.50M$-72.03M$-54.42M$-73.84M$-56.20M$-21.99M$47.64M
Surprise %-33.65%-6.51%-9.41%5.69%13.97%---

OCGN Forecast FAQ

Is Ocugen stock a buy?

Ocugen stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Ocugen is a favorable investment for most analysts.

What is Ocugen's price target?

Ocugen's price target, set by 5 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $3.5 at the low end to $6 at the high end, suggesting a potential 101.61% change from the previous closing price of $2.48.

How does Ocugen stock forecast compare to its benchmarks?

Ocugen's stock forecast shows a 101.61% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Ocugen over the past three months?

  • March 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Ocugen’s EPS forecast?

Ocugen's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.22, marking a -4.35% decrease from the reported $-0.23 in 2025. Estimates for the following years are $0.39 in 2027, and $0.2 in 2028.

What is Ocugen’s revenue forecast?

Ocugen's average annual revenue forecast for its fiscal year ending in December 2026 is $20.57M, reflecting a 366.15% increase from the reported $4.41M in 2025. The forecast for 2027 is $99.54M, and $219.66M for 2028.

What is Ocugen’s net income forecast?

Ocugen's net income forecast for the fiscal year ending in December 2026 stands at $-52.53M, representing a -22.57% decrease from the reported $-67.846M in 2025. Projections indicate $-8.342M in 2027, and $47.64M in 2028.